Osteoarthritis is a disease. It is the most common form of arthritis in the world, affecting roughly 607 million people as of 2021. While it was long dismissed as simple “wear and tear” on aging joints, the medical understanding has shifted significantly: osteoarthritis is now recognized as a complex disease of the entire joint, driven by biological processes that actively break down tissue, not just passive mechanical erosion.
Why It’s a Disease, Not Just Wear and Tear
The outdated view of osteoarthritis treated it as an inevitable consequence of using your joints over time, like brake pads wearing thin. That framing suggested it was a condition rather than a disease, something that simply happened with age. Modern research tells a different story.
Osteoarthritis involves an active cascade of inflammatory signaling molecules that drive the destruction of joint tissue. When cartilage is damaged, cells in the joint release inflammatory chemicals that trigger a chain reaction. These signals activate enzymes that break down the structural matrix of cartilage, essentially digesting it from within. The process is self-reinforcing: damaged tissue releases more inflammatory signals, which recruit more destructive enzymes, which cause more damage. This is not passive wearing down. It is an active disease process with identifiable biological mechanisms.
The joint cells themselves change their behavior during osteoarthritis. Cartilage cells begin to proliferate abnormally, forming clusters. They shift into a different functional state, producing bony outgrowths called osteophytes (bone spurs) instead of maintaining healthy cartilage. Eventually, many of these cells die off entirely. The complete biological pathway that leads to full joint destruction is still not entirely mapped, but enough is understood to classify osteoarthritis firmly as a disease rather than a normal aging process.
The Entire Joint Is Affected
One of the clearest reasons osteoarthritis qualifies as a disease is that it involves the entire joint organ, not just cartilage. During its development, articular cartilage, subchondral bone (the bone just beneath cartilage), the synovial tissue that lines the joint, the meniscus, ligaments, and the joint capsule are all affected. The earliest visible changes typically appear in the cartilage surface, which develops roughening, irregularity, and small erosions. These erosions gradually extend down to the bone and spread across more of the joint surface.
Beneath the cartilage, the bone thickens abnormally due to improperly formed collagen. In advanced cases, fluid-filled cysts can develop within the bone. The synovium, the membrane that produces lubricating fluid inside the joint, becomes inflamed and thickened. Soft tissue structures like ligaments and the joint capsule deteriorate as well. This widespread, multi-tissue involvement is characteristic of a systemic disease process, not localized mechanical damage.
Two Types With Different Causes
Osteoarthritis is classified into two categories. Primary osteoarthritis, the most common form, develops without any obvious preceding injury or underlying condition. It is associated with risk factors like age, genetics, obesity, and joint mechanics, but there is no single identifiable trigger. Secondary osteoarthritis develops as a consequence of something specific: a joint injury, a prior surgery, a congenital limb abnormality, or another disease such as gout, rheumatoid arthritis, or metabolic conditions like hemochromatosis.
The distinction matters because secondary osteoarthritis can sometimes appear in younger people or in joints that wouldn’t typically be affected. A knee injured in a sports accident, for example, carries a significantly higher risk of developing osteoarthritis years later, regardless of the person’s age or weight.
Inflammation and Metabolism Play Central Roles
The inflammatory component of osteoarthritis is now well established. Inflammatory molecules produced by damaged cartilage cells and the joint lining drive a destructive feedback loop. These molecules interfere with the production of essential structural proteins like collagen and aggrecan, which are the building blocks of healthy cartilage. At the same time, they stimulate enzymes that actively degrade what cartilage remains. The process also generates reactive oxygen species, unstable molecules that cause further cellular damage.
Beyond local joint inflammation, systemic metabolic factors contribute to a specific subtype called metabolic osteoarthritis. People with metabolic syndrome (a combination of obesity, high blood sugar, abnormal cholesterol, and high blood pressure) face elevated risk, and each individual component adds to that risk independently. Fat tissue acts as an endocrine organ, releasing inflammatory molecules into the bloodstream that can reach and damage joints throughout the body. This helps explain why obesity is linked to osteoarthritis even in non-weight-bearing joints like the hands: the connection is not purely about mechanical load, but about body-wide inflammation. For every 5-unit increase in BMI, the risk of knee osteoarthritis rises by about 35%.
Who Gets It
Osteoarthritis is strikingly common. Globally, about 607 million people were living with it in 2021, with approximately 466 million new cases diagnosed that year alone. In high-income North America, prevalence exceeded 51 million cases. Among people over 55, the average prevalence rate is 13.2%, but the burden falls unevenly: 18% of women in that age group have osteoarthritis compared to 9.4% of men. Over the past two decades, incidence rates have doubled in men and tripled in women in the United States.
How Severity Is Measured
Doctors grade osteoarthritis severity using X-rays, most commonly with the Kellgren-Lawrence scale, which runs from 0 to 4. Grade 0 means no signs of the disease. Grade 1 shows possible early bone spur formation with questionable narrowing of the joint space. Grade 2 involves definite bone spurs with possible joint space narrowing. Grade 3 shows clear narrowing, moderate bone spurs, some bone thickening, and possible changes to the shape of the bone ends. Grade 4 represents severe disease: large bone spurs, significant loss of joint space, pronounced bone thickening, and visible deformity of the bone.
It’s worth noting that X-ray severity doesn’t always match symptom severity. Some people with Grade 2 changes on imaging report significant pain, while others with Grade 3 or 4 changes function relatively well. This disconnect is another reason osteoarthritis is considered a complex disease rather than a straightforward mechanical problem: the biology driving symptoms involves inflammation, nerve sensitization, and metabolic factors that an X-ray simply cannot capture.